Budget impact of iv iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany

21 May 2016 (00:00 - 00:00)

Organised by:

Sign in for access options

About the speaker

Mrs Ulrike Theidel

Xcenda GmbH, Hannover (Germany)

23 More presentations in this session

Presentation thumbnail

Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up.

Associate Professor D. D'Amario (Novara, IT)

Presentation thumbnail

Ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta-analysis of randomized, double-blinded clinical trials

Professor V. Mitrovic (Nauheim, DE)

Presentation thumbnail

Ivabradine reduces early readmission after hospitalization for worsening heart failure: a post-hoc analysis of SHIFT

Professor M. Komajda (Paris, FR)

Presentation thumbnail

Favorable long-term mortality profile in nyha iii/iv patients treated with cardiac contractility modulation (CCM)

Professor D. Burkhoff (New York, US)

Presentation thumbnail

First transcatheter intracardiac shunt device to reduce left atrial pressure in heart failure with preserved ejection fraction; the REDUCE elevated levt atrial pressure in patients with heart failure

Professor G. Hasenfuss (Goettingen, DE)

Access the full session

Session thumbnail

Clinical Forum - Sat. 21 May 08:30 - Sun. 22 May 18:00

The Event

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources